Bismuth

Bismuth poisoning can resemble a neurological illness. Confusion, muscle jerks, slurred speech, and unsteady walking have occurred after prolonged use of bismuth medicines and absorption from surgical dressings. A whole-blood bismuth measurement can help investigate that possibility, especially when your exposure history fits.

This is an established toxicology measurement for assessing exposure and suspected poisoning. Its usefulness as a routine longevity screen hasn't been demonstrated. The concentration needs to be interpreted with your symptoms, kidney function, product, dose, and duration of use; detecting absorbed bismuth does not by itself establish poisoning.

What a Blood Level Shows

The test measures total bismuth in whole blood, including the metal in blood cells and the surrounding fluid. The laboratory uses ICP-MS to identify and measure the element by its atomic mass. The result reflects recent absorption, clearance, and release from tissue stores.

Most swallowed bismuth passes through the gut without being absorbed, though absorption varies by compound. In a study of 20 healthy men given colloidal bismuth subcitrate, total blood concentrations rose rapidly during the first hour. Most of the administered bismuth left through stool. Urine contained 0.03% to 1.2% of the swallowed dose during the study's collection period. That percentage describes the administered dose, most of which never entered the bloodstream.

The same study detected traces of trimethylbismuth in blood and exhaled breath. Experiments with intestinal microbes suggest they can produce this compound, but the human study did not establish where it formed. This is a separate chemical form within the broader measurement of total bismuth.

Clearance occurs in several phases and varies with the compound, duration of exposure, and kidney function. A single fixed half-life cannot reliably predict when your whole-blood result will return to its previous level. In one severe overdose, blood bismuth remained detectable 96 days after ingestion.

Where Exposure Comes From

• Stomach medicines: bismuth subsalicylate is used for diarrhea and indigestion. Bismuth subcitrate and other compounds are used in some ulcer and H. pylori treatments. Absorption differs between formulations.
• Surgical dressings: bismuth iodoform paraffin paste is used to pack certain wounds and surgical cavities. Absorption from this packing has caused poisoning in reported cases, including after jaw surgery.
• Dental materials: some root canal repair materials contain bismuth oxide so they show up on X-rays. Laboratory and animal studies have found release into surrounding tissues, blood, and organs. These findings have not established that routine root canal treatment causes systemic poisoning in people.
• Work and industry: bismuth is recovered mainly as a byproduct of other metal production and is used in some lead-free alloys. The relevance of testing depends on actual contact with bismuth-containing materials, including dust, rather than a job title alone.
• Cosmetics: some products contain bismuth compounds. Their presence in a cosmetic does not establish that enough has been absorbed to cause toxicity.

Brain Effects

Encephalopathy is a disorder of brain function. Bismuth-related encephalopathy can cause confusion, memory changes, muscle jerks, tremor, slurred speech, unsteady walking, and sometimes hallucinations. A historical series described 45 people admitted with this syndrome while taking bismuth subnitrate. They were selected because they were ill, so the series cannot tell you how often poisoning occurs among everyone who takes the medicine.

Published cases show considerable variation in blood concentrations and symptoms. A blood result measures circulating exposure; it does not directly measure the amount in your brain or the severity of injury. Short prescribed courses have generally been well tolerated, while excessive or prolonged use and impaired kidney function feature in many poisoning reports.

Kidney Injury

The kidneys help eliminate absorbed bismuth, and substantial exposure can also injure them. Human overdose reports describe reduced urine output, protein in urine, and rising blood waste products. Kidney biopsies in some cases showed damage to the cells lining the kidney's small tubes. Much of this evidence comes from individual poisoning cases, which establish that injury can occur but do not define the risk from ordinary low exposure.

Reduced kidney function can slow clearance and increase the risk of accumulation. In one often-cited case, a man with chronic kidney failure developed encephalopathy after taking twice the recommended dose of a bismuth ulcer medicine for two months. That case involved both impaired clearance and excessive dosing.

Pregnancy and Newborn Growth

A study of 471 newborns measured bismuth in umbilical cord blood, a different specimen and biological setting from an adult blood draw. Newborns in the highest tenth of cord-blood bismuth concentrations had about five times the odds of being small for gestational age compared with the others. The outcome was birth weight below the tenth percentile for gestational age. The estimate was imprecise, and the study assessed exposure and growth at delivery, so it cannot establish that bismuth caused the difference.

A separate study of 152 women included women with first-trimester miscarriage, women with ongoing pregnancies, and nonpregnant controls. It found higher bismuth in serum among the miscarriage group. Serum is different from whole blood, and samples collected around a miscarriage cannot establish whether the metal contributed to it. Neither study validated adult whole-blood testing to predict pregnancy outcomes or showed that lowering a result improves them.

When Results Can Be Misleading

• Recent medication: a dose can temporarily raise the concentration. The size and timing of that rise depend on the formulation. A result during prescribed treatment can document absorption without indicating poisoning.
• Kidney function: reduced clearance can produce a higher concentration from the same exposure. This is a real biological change that needs kidney-function context.
• Rebound after dialysis: blood concentrations have fallen temporarily and then risen again in overdose cases, consistent with redistribution from tissue stores. An immediate post-dialysis result can give an incomplete picture.
• Different specimens: whole blood, plasma, serum, and urine measure different compartments or routes of elimination. Their values are not interchangeable, and a fixed conversion between them is unreliable.
• Collection contamination: metal contamination from collection equipment, skin, or workplace dust can falsely increase a trace-metal result.
• Recent imaging contrast: gadolinium- or iodine-containing contrast can interfere with ICP-MS metal testing. The timing of recent imaging belongs with the result.

Tracking Your Trend

Serial measurements can help follow a documented exposure or poisoning episode. Interpretation depends on comparable specimen collection and the timing of medication, treatment, and kidney-function changes. A falling concentration can accompany clearance, while a plateau may reflect continuing exposure or release from tissue stores. The trend alone cannot distinguish those explanations.